Used in biomedical research to quantify levels of the RAGE protein in biological samples such as serum, plasma, cell lysates, and tissue homogenates. This assay is particularly valuable in studies related to chronic inflammatory diseases, diabetes and its complications, neurodegenerative disorders like Alzheimer's disease, and cardiovascular conditions. By measuring RAGE concentration, researchers can assess the activation of inflammatory pathways and evaluate the progression or severity of diseases associated with advanced glycation end products (AGEs). The kit supports high-throughput analysis with high specificity and sensitivity, making it a reliable tool for both basic research and preclinical studies. It is not intended for diagnostic use in humans but serves as a critical component in understanding disease mechanisms and developing potential therapeutic interventions.